Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccine
Top Cited Papers
Open Access
- 21 January 2021
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 96 (5), E133-E134
- https://doi.org/10.1002/ajh.26106
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesThe New England Journal of Medicine, 2020
- An mRNA Vaccine against SARS-CoV-2-Preliminary ReportThe New England Journal of Medicine, 2020
- American Society of Hematology 2019 guidelines for immune thrombocytopeniaBlood Advances, 2019
- The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reportsAmerican Journal of Hematology, 2010
- Drug-induced thrombocytopenia: pathogenesis, evaluation, and managementHematology, 2009